Found 0 matching trials
Sequential Conditioning in Haploidentical Transplantation for Refractory Acute Myeloid Leukemia NA Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only ...
Show More Location
Service d'hématologie Clinique Hôpital Saint Antoine
Learn More & Join Trial
Transplantation of Ex-vivo Expanded Cord Blood Stems Cells PHASE2 This program offers the opportunity to receive an allogeneic transplant to ...
Show More Location
Service d'hématologie et d'Oncologie Clinique - Hôpital Lapeyronie - 371 avenue du Doyen Gaston GIRAUD
Learn More & Join Trial
Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial PHASE3 ASSIST I was the first randomized trial in patients with scleroderma to not...
Show More Location
Northwestern University
Learn More & Join Trial
A Study of TCD601 in the Induction of Tolerance in Renal Transplantation (PANORAMA) PHASE2 The purpose of this study is to determine the optimal regimen for the use o...
Show More Location
Columbia University Irving Medical Center
Learn More & Join Trial
Azacytidine Prior to in Vivo T-cell Depleted Allo Stem Cell Transplant for Patients With Myeloid Malignancies in CR PHASE2 The purpose of this study is to determine whether 5-Azacytidine priming bef...
Show More Location
Weill Cornell Medical College
Learn More & Join Trial
Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients With Dyskeratosis Congenita PHASE2 Dyskeratosis congenita is a disease that affects numerous parts of the body...
Show More Status
Active Not Recruiting
Location
University of Chicago
Learn More & Join Trial
Reduced Intensity Conditioning (RIC) Regimen for Patients With Non-malignant Disorders PHASE2 This Phase II pilot study evaluates the safety and effectiveness of reduced...
Show More Location
The Children's Hospital of Philadelphia
Learn More & Join Trial
Allogeneic Stem Cell Transplantation (SCT) After Dose-reduced Conditioning for Myelofibrosis Patients PHASE2 The purpose of this study is to determine whether a reduced intensity condi...
Show More Location
University Medical Center Hamburg-Eppendorf
Learn More & Join Trial
Penostatin, Rituximab and Ontak and Allogeneic Natural Killer (NK) Cells for Refractory Lymphoid Malignancies PHASE2 In this study the investigators investigate a cell therapy strategy that co...
Show More Location
Masonic Cancer Center, University of Minnesota
Learn More & Join Trial
Propylene Glycol-Free Melphalan HCl (EVOMELA®) in Combination With Fludarabine and Total Body Irradiation Based Reduced Intensity Conditioning for Haploidentical Transplantation PHASE2 This is an open-label, single-arm, phase II study to determine the safety o...
Show More Location
Froedtert Hospital & the Medical College of Wisconsin
Learn More & Join Trial